Home › Zacks Investment Research Lowers Galena Biopharma Inc (GALE) to Hold
 

Keywords :   


Zacks Investment Research Lowers Galena Biopharma Inc (GALE) to Hold

2016-02-08 05:03:48| Biotech - Topix.net

According to Zacks, "Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena Biopharma, Inc., formally known as RXi Pharmaceuticals Corporation, is based in Portland, Oregon.

Tags: research hold investment gale

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
31.10Unicharm to Expand in Africa
31.10Essity Named Diversity Leader by Financial Times
31.10Maxcess to Make FIFE Guiding Products in Mumbai
31.10Renee Starr Joins Hospeco
31.10RRD expands emissions reduction efforts
31.10Label King wins Best-In-Class for sustainability with Mark Andy
31.10Liberty Global video subscribers down 31,100 in 3Q 2024
31.10Eunha Fisheries installs Anytron ANY-JET III digital label printer
More »